Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
Objective: To evaluate virologic response rates of lopinavir/ritonavir (LPV/r) monotherapy as second-line antiretroviral treatment (ART) among adults in resource-limited settings (RLSs). Design: An open-label pilot study of LPV/r monotherapy in participants on first-line nonnucleoside reverse transc...
محفوظ في:
المؤلفون الرئيسيون: | Bartlett J., Ribaudo H., Wallis C., Aga E., Katzenstein D., Stevens W., Norton M., Klingman K., Hosseinipour M., Crump J., Supparatpinyo K., Badal-Faesen S., Kallungal B., Kumarasamy N. |
---|---|
التنسيق: | دورية |
منشور في: |
2017
|
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84863718841&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/42812 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings
بواسطة: John A. Bartlett, وآخرون
منشور في: (2018) -
Lopinavir/ritonavir monotherapy as second-line antiretroviral treatment in resource-limited settings: Week 104 analysis of AIDS clinical trials group (ACTG) A5230
بواسطة: Kumarasamy N., وآخرون
منشور في: (2015) -
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
بواسطة: Kulkanya Chokephaibulkit, وآخرون
منشور في: (2018) -
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
بواسطة: Chokephaibulkit K., وآخرون
منشور في: (2014) -
Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavir
بواسطة: Kulkanya Chokephaibulkit, وآخرون
منشور في: (2018)